Profile
VALN VRTX REGN VRNA ARGX ALNY
Company Name Valneva SE Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $787.31M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.71K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Thomas Lingelbach Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
VALN VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
VALN VRTX REGN VRNA ARGX ALNY
Last Close $8.89 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $12.2 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $3.69 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -27.13 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 140.92 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
VALN VRTX REGN VRNA ARGX ALNY
1 Month Return -11.45 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -26.77 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 41.79 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 21.28 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 103.34 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 94.96 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VALN VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -0.53 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
VALN VRTX REGN VRNA ARGX ALNY
Asset Growth 8.69 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 34.45 % 1.16 % - 26.81 %
Revenue Growth 10.32 % 0.99 % - 22.97 %
Revenue 3 Year -66.16 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year -12.27 % 73.64 % - 775.72 %
Revenue 10 Year 81.36 % 285.02 % - 2487.4 %
EBIT Growth 116.6 % 9.09 % -131.37 % 24.59 %
Net Income Growth 87.93 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 88.41 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -358.46 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 81.59 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 116.24 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 66.85 % - -143.33 % -107.98 %
Operating 3 Year CFG -160.72 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -893.7 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -77.62 % -100 % 40.15 % 97.08 %
EPS Growth 88.05 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 88.05 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 39.74 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -26.19 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -12.45 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -42.48 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 3.59 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 61.46 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
VALN VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 47.58 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -26.02 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -64.69 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -26.42 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 106.98 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 125.42 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -33.03 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -6.04 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 11.5 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.59 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 0.05 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 188.18 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 58.71 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.07 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.21 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 99.33 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -4.29 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 288.98 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -6.04 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -19.46 36.72 20 -995.27 128.45 195.85
Price To Operating Cash Flows Ratio TTM -53.06 32.86 16.23 -126.33 145.01 162.25
Price Cash Flow Ratio TTM -53.06 32.86 16.23 -126.33 145.01 162.25
Income Statement (TTM)
VALN VRTX REGN VRNA ARGX ALNY
Revenue $0.17B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0.07B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 41.89% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $0.03B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -0.17 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
VALN VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.19B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.32B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.18B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $16.08B $0.02B $1.93B $1.73B
Total Debt $0.22B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.5B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
VALN VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $-0.01B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.07B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0.02B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.52
AARD Aardvark Therapeutics, Inc. Common Stock 12.65
ABCL AbCellera Biologics Inc. 3.16
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.13
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.4
ABPWW 0.0155
ABSI Absci Corporation 2.695
ABUS Arbutus Biopharma Corporation 3.84
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 117.67
ACAD ACADIA Pharmaceuticals Inc. 23.56
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.03
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.25
ACIU AC Immune SA 3.14
ETFs With Exposure to VALN
Ticker ETF Name Weight Percentage Price
IEFA iShares Core MSCI EAFE ETF 0.01 95.66
IXUS iShares Core MSCI Total International Stock ETF 0.01 90.93
SCZ iShares MSCI EAFE Small-Cap ETF 0.04 83.23
IEUS iShares MSCI Europe Small-Cap ETF 0.01 72.41
IDEV iShares Core MSCI International Developed Markets ETF 0.01 87.91
XEU.TO iShares MSCI Europe IMI Index ETF 0.01 39.35
XEF.TO iShares Core MSCI EAFE IMI Index ETF 0 49.27
WSML.L iShares MSCI World Small Cap UCITS ETF 0.02 9.746
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.02 8.261
WLDS.L iShares MSCI World Small Cap UCITS ETF 0.02 7.163
Unlock